Clinical Trial Update: Impact of Adjuvant Treatment With Aromatase Inhibitor on Sleep Disturbances in Postmenopausal Women With Endocrine Responsive Early Breast Cancer

View source ↗

Summary

A clinical trial update evaluating whether adjuvant aromatase inhibitor therapy affects sleep disturbances in postmenopausal women with endocrine-responsive ear…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Aromasin (exemestane)
• FEMARA (letrozole)

Snippet

Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Conditions: Endocrine Responsive Early Breast Cancer | Status: UNKNOWN